Document
APIXABAN FORMULATIONS, 13/579,796, No. 1-1-US-135797962OP1 (U.S. Pat. App. Mar. 27, 2018)
Cite Document
APIXABAN FORMULATIONS, 13/579,796, No. 1-1-US-135797962OP1 (U.S. Pat. App. Mar. 27, 2018)
+ More Snippets
Document
APIXABAN FORMULATIONS, 13/579,796, No. 1-1-US-135797962NP1 (U.S. Pat. App. Mar. 27, 2018)
Cite Document
APIXABAN FORMULATIONS, 13/579,796, No. 1-1-US-135797962NP1 (U.S. Pat. App. Mar. 27, 2018)
+ More Snippets
Document
APIXABAN FORMULATIONS, 13/579,796, No. 1-1-US-135797962MP1 (U.S. Pat. App. Mar. 15, 2018)
Cite Document
APIXABAN FORMULATIONS, 13/579,796, No. 1-1-US-135797962MP1 (U.S. Pat. App. Mar. 15, 2018)
+ More Snippets
Document
APIXABAN FORMULATIONS, 13/579,796, No. 1-36-US-1357979631P1 (U.S. Pat. App. Oct. 15, 2018)
Cite Document
APIXABAN FORMULATIONS, 13/579,796, No. 1-36-US-1357979631P1 (U.S. Pat. App. Oct. 15, 2018)
+ More Snippets
Document
IPR2018-00892, No. 1017-16 Exhibit - Ex 1017 US Provisional Application 61308,056 (P.T.A.B. Apr. 5, 2018)
Cite Document
IPR2018-00892, No. 1017-16 Exhibit - Ex 1017 US Provisional Application 61308,056 (P.T.A.B. Apr. 5, 2018)
+ More Snippets
Document
IPR2018-00892, No. 2002-37 Exhibit - DECLARATION OF AMY K WIGMORE IN SUPPORT OFMOTION FOR ADMISSION PRO HAC VICE (P.T.A.B. May. 16, 2018)
Cite Document
IPR2018-00892, No. 2002-37 Exhibit - DECLARATION OF AMY K WIGMORE IN SUPPORT OFMOTION FOR ADMISSION PRO HAC VICE (P.T.A.B. May. 16, 2018)
+ More Snippets
Document
IPR2018-00892, No. 1044 Exhibit - Ex 1044 Second Supplemental Declaration of Kinam Park, PhD (P.T.A.B. Nov. 26, 2018)
Cite Document
IPR2018-00892, No. 1044 Exhibit - Ex 1044 Second Supplemental Declaration of Kinam Park, PhD (P.T.A.B. Nov. 26, 2018)
+ More Snippets
Document
IPR2018-00892, No. 1042 Exhibit - Ex 1042 Rudnic, 3rd edition, Modern Pharmaceutics (P.T.A.B. Nov. 26, 2018)
Cite Document
IPR2018-00892, No. 1042 Exhibit - Ex 1042 Rudnic, 3rd edition, Modern Pharmaceutics (P.T.A.B. Nov. 26, 2018)
+ More Snippets
Document
IPR2018-00892, No. 2004 Exhibit - John A Heit, Epidemiology of venous thromboembolism (P.T.A.B. Jul. 18, 2018)
Cite Document
IPR2018-00892, No. 2004 Exhibit - John A Heit, Epidemiology of venous thromboembolism (P.T.A.B. Jul. 18, 2018)
+ More Snippets
Document
IPR2018-00892, No. 1045 Exhibit - Ex 1045 Declaration of Karen L Carroll (P.T.A.B. Nov. 26, 2018)
Cite Document
IPR2018-00892, No. 1045 Exhibit - Ex 1045 Declaration of Karen L Carroll (P.T.A.B. Nov. 26, 2018)
+ More Snippets
Document
IPR2018-00892, No. 2012 Exhibit - The Merck Index An Encyclopedia of Chemicals, Drugs, and Biologicals (P.T.A.B. Jul. 18, 2018)
Cite Document
IPR2018-00892, No. 2012 Exhibit - The Merck Index An Encyclopedia of Chemicals, Drugs, and Biologicals (P.T.A.B. Jul. 18, 2018)
+ More Snippets
Document
IPR2018-00892, No. 2003 Exhibit - Sumeet S Chugh et al, Worldwide Epidemiology of Atrial Fibrillation (P.T.A.B. Jul. 18, 2018)
Cite Document
IPR2018-00892, No. 2003 Exhibit - Sumeet S Chugh et al, Worldwide Epidemiology of Atrial Fibrillation (P.T.A.B. Jul. 18, 2018)
+ More Snippets
Document
IPR2018-00892, No. 2010 Exhibit - Coal for Affordable Drugs IX LLC v Bristol Myers Squibb Co, Decision Denying Institution of Inter Partes Review (P.T.A.B. Jul. 18, 2018)
Cite Document
IPR2018-00892, No. 2010 Exhibit - Coal for Affordable Drugs IX LLC v Bristol Myers Squibb Co, Decision Denying Institution of Inter Partes Review (P.T.A.B. Jul. 18, 2018)
+ More Snippets
Document
IPR2018-00892, No. 2009 Exhibit - Pancras C Wong et al, Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor (P.T.A.B. Jul. 18, 2018)
Cite Document
IPR2018-00892, No. 2009 Exhibit - Pancras C Wong et al, Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor (P.T.A.B. Jul. 18, 2018)
+ More Snippets
Document
IPR2018-00892, No. 1017 Exhibit - Ex 1017 US Provisional Application 61308,056 (P.T.A.B. Apr. 5, 2018)
Cite Document
IPR2018-00892, No. 1017 Exhibit - Ex 1017 US Provisional Application 61308,056 (P.T.A.B. Apr. 5, 2018)
+ More Snippets